INOVIO Receives U.S. FDA Authorization to Proceed with INNOVAT...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
PLYMOUTH MEETING, Pa., Nov. 9, 2021 /PRNewswire-AsiaNet/ -- - FDA Lifts Partial Clinical Hold on INNOVATE Phase 3 Segment INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to help protect people from infectious diseases and treat cancer and HPV...
Authors: LATEST ASIANET NEWS RELEASES